1.Research progresses of diffusion MRI for schizophrenia
Ying LI ; Nian LIU ; Hangyu LI ; Shiji PENG ; Xinyue CHEN ; Rui YU ; Kaike LIAO
Chinese Journal of Medical Imaging Technology 2025;41(6):981-984
Schizophrenia(SZ)is a psychiatric disorder characterized by abnormalities in brain structures and function.Diffusion MRI,such as diffusion tensor imaging(DTI),diffusion kurtosis imaging(DKI),diffusion spectrum imaging(DSI),neurite orientation dispersion and density imaging(NODDI),as well as high angular resolution diffusion imaging(HARDI)can help reveal microstructural abnormalities of white matter in SZ patients.The research progresses of diffusion MRI for SZ were reviewed in this article.
2.Research progresses of task state functional MRI in pathogenesis of non-suicidal self-injury
Shiji PENG ; Nian LIU ; Ying LI ; Hangyu LI ; Rui YU ; Kaike LIAO ; Xinyue CHEN
Chinese Journal of Medical Imaging Technology 2025;41(3):494-497
Non-suicidal self-injury(NSSI)refers to a mental disorder characterized by deliberate self-harm behaviors without suicidal intent.The pathogenesis of NSSI remains unclear,but may be related to abnormalities in reward circuitry,pain processing,emotion regulation,impulse control and hypothalamic-pituitary-adrenal axis.Task state functional MRI(fMRI)provides valuable insights into the intrinsic connections and neural circuits mechanisms underlying NSSI during various task states or behaviors.Research progresses of task state fMRI in pathogenesis of NSSI were reviewed in this article.
3.Research progresses of task state functional MRI in pathogenesis of non-suicidal self-injury
Shiji PENG ; Nian LIU ; Ying LI ; Hangyu LI ; Rui YU ; Kaike LIAO ; Xinyue CHEN
Chinese Journal of Medical Imaging Technology 2025;41(3):494-497
Non-suicidal self-injury(NSSI)refers to a mental disorder characterized by deliberate self-harm behaviors without suicidal intent.The pathogenesis of NSSI remains unclear,but may be related to abnormalities in reward circuitry,pain processing,emotion regulation,impulse control and hypothalamic-pituitary-adrenal axis.Task state functional MRI(fMRI)provides valuable insights into the intrinsic connections and neural circuits mechanisms underlying NSSI during various task states or behaviors.Research progresses of task state fMRI in pathogenesis of NSSI were reviewed in this article.
4.Research progresses of diffusion MRI for schizophrenia
Ying LI ; Nian LIU ; Hangyu LI ; Shiji PENG ; Xinyue CHEN ; Rui YU ; Kaike LIAO
Chinese Journal of Medical Imaging Technology 2025;41(6):981-984
Schizophrenia(SZ)is a psychiatric disorder characterized by abnormalities in brain structures and function.Diffusion MRI,such as diffusion tensor imaging(DTI),diffusion kurtosis imaging(DKI),diffusion spectrum imaging(DSI),neurite orientation dispersion and density imaging(NODDI),as well as high angular resolution diffusion imaging(HARDI)can help reveal microstructural abnormalities of white matter in SZ patients.The research progresses of diffusion MRI for SZ were reviewed in this article.
5.Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer.
Xumin ZHOU ; Libin ZOU ; Hangyu LIAO ; Junqi LUO ; Taowei YANG ; Jun WU ; Wenbin CHEN ; Kaihui WU ; Shengren CEN ; Daojun LV ; Fangpeng SHU ; Yu YANG ; Chun LI ; Bingkun LI ; Xiangming MAO
Acta Pharmaceutica Sinica B 2022;12(2):692-707
Owing to incurable castration-resistant prostate cancer (CRPC) ultimately developing after treating with androgen deprivation therapy (ADT), it is vital to devise new therapeutic strategies to treat CRPC. Treatments that target programmed cell death protein 1 (PD-1) and programmed death ligand-1 (PD-L1) have been approved for human cancers with clinical benefit. However, many patients, especially prostate cancer, fail to respond to anti-PD-1/PD-L1 treatment, so it is an urgent need to seek a support strategy for improving the traditional PD-1/PD-L1 targeting immunotherapy. In the present study, analyzing the data from our prostate cancer tissue microarray, we found that PD-L1 expression was positively correlated with the expression of heterogeneous nuclear ribonucleoprotein L (HnRNP L). Hence, we further investigated the potential role of HnRNP L on the PD-L1 expression, the sensitivity of cancer cells to T-cell killing and the synergistic effect with anti-PD-1 therapy in CRPC. Indeed, HnRNP L knockdown effectively decreased PD-L1 expression and recovered the sensitivity of cancer cells to T-cell killing in vitro and in vivo, on the contrary, HnRNP L overexpression led to the opposite effect in CRPC cells. In addition, consistent with the previous study, we revealed that ferroptosis played a critical role in T-cell-induced cancer cell death, and HnRNP L promoted the cancer immune escape partly through targeting YY1/PD-L1 axis and inhibiting ferroptosis in CRPC cells. Furthermore, HnRNP L knockdown enhanced antitumor immunity by recruiting infiltrating CD8+ T cells and synergized with anti-PD-1 therapy in CRPC tumors. This study provided biological evidence that HnRNP L knockdown might be a novel therapeutic agent in PD-L1/PD-1 blockade strategy that enhanced anti-tumor immune response in CRPC.

Result Analysis
Print
Save
E-mail